JP Morgan Chase
EDIT icon

JP Morgan Chase’s Editas Medicine EDIT Stock Holding History

JP Morgan Chase’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23,200
Closed -$974K – 6402
2021
Q1 		$974K Hold
23,200
– – ﹤0.01% 4255
2020
Q4 		$1.63M Buy
+23,200
New +$953K ﹤0.01% 3630
2019
Q1 		– Sell
-110,000
Closed -$2.5M – 5827
2018
Q4 		$2.5M Buy
+110,000
New +$2.99M ﹤0.01% 3121
2018
Q3 		– Sell
-45,000
Closed -$1.61M – 5699
2018
Q2 		$1.61M Sell
45,000
-35,000
-44% -$1.24M ﹤0.01% 3549
2018
Q1 		$2.65M Buy
80,000
+40,000
+100% +$1.43M ﹤0.01% 3068
2017
Q4 		$1.23M Buy
+40,000
New +$1.01M ﹤0.01% 3602

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

JP Morgan Chase's EDIT Position: Q2 2026 in Review

JP Morgan Chase reduced its Editas Medicine (EDIT) stake by 4.4% in Q2 2026, selling an estimated $248K and leaving 1,862,494 shares worth $5.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3294.

JP Morgan Chase first reported a position in EDIT in Q1 2016 and has held it in 40 quarters since. The position peaked at $62.4M in Q2 2021. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • JP Morgan Chase held 1,862,494 shares of Editas Medicine worth $5.96M as of Q2 2026.
  • JP Morgan Chase sold 84,890 Editas Medicine shares in Q2 2026, an estimated $248K.
  • Editas Medicine made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3294 holding.
  • JP Morgan Chase first reported a position in Editas Medicine in Q1 2016 and has held it in 40 quarters since.
  • JP Morgan Chase's Editas Medicine position peaked at $62.4M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.